Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/4227
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Sodium Chloride (Injection, Solution)
|
| dailymed-instance:descripti... |
3% and 5% Sodium
Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution
for fluid and electrolyte replenishment in single dose containers for
intravenous administration. The pH may have been adjusted with
hydrochloric acid. It contains no antimicrobial agents. Composition,
ionic concentration, osmolarity, and pH are shown in Table 1. The VIAFLEX plastic
container is fabricated from a specially formulated polyvinyl chloride
(PL 146 Plastic). The amount of water that can permeate from inside the
container into the overwrap is insufficient to affect the solution
significantly. Solutions in contact with the plastic container can leach
out certain of its chemical components in very small amounts within the
expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts
per million. However, the safety of the plastic has been confirmed in
tests in animals according to USP biological tests for plastic
containers as well as by tissue culture toxicity studies.
|
| dailymed-instance:clinicalP... |
3% and 5% Sodium
Chloride Injection, USP has value as a source of water and electrolytes.
It is capable of inducing diuresis depending on the clinical condition
of the patient.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:contraind... |
None
known
|
| dailymed-instance:supply |
3% and 5% Sodium
Chloride Injection, USP in VIAFLEX plastic container is available as
follows: Exposure of
pharmaceutical products to heat should be minimized. Avoid excessive
heat. It is recommended the product be stored at room temperature
(25��C); brief exposure up to 40��C does not adversely affect the
product.<br/>Directions for Use
of VIAFLEX Plastic Container: Warning: Do not use plastic
containers in series connections. Such use could result in air
embolism due to residual air being drawn from the primary
container before administration of the fluid from the secondary
container is completed.<br/>To Open: Tear
overwrap down side at slit and remove solution container. Some
opacity of the plastic due to moisture absorption during the
sterilization process may be observed. This is normal and does
not affect the solution quality or safety. The opacity will
diminish gradually. Check for minute leaks by squeezing inner
bag firmly. If leaks are found, discard solution as sterility
may be impaired. If supplemental medication is desired, follow
directions below.<br/>Preparation for
Administration:<br/>To Add Medication: Warning: Additives may be
incompatible.<br/>To add
medication before solution administration:<br/>To add
medication during solution administration: Baxter Healthcare
Corporation Deerfield, IL 60015 USA Printed in USA
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:genericMe... |
Sodium Chloride
|
| dailymed-instance:fullName |
Sodium Chloride (Injection, Solution)
|
| dailymed-instance:adverseRe... |
Reactions which may
occur because of the solution or the technique of administration include
febrile response, infection at the site of injection, venous thrombosis
or phlebitis extending from the site of injection, extravasation and
hypervolemia. If an adverse
reaction does occur, discontinue the infusion, evaluate the patient,
institute appropriate therapeutic countermeasures, and save the
remainder of the fluid for examination if deemed necessary.
|
| dailymed-instance:warning |
3% and 5% Sodium
Chloride Injection, USP is strongly hypertonic and may cause vein
damage. 3% and 5% Sodium
Chloride Injection, USP should be used with great care, if at all, in
patients with congestive heart failure, severe renal insufficiency, and
in clinical states in which there exists edema with sodium retention. In patients with
diminished renal function, administration of 3% and 5% Sodium Chloride
Injection, USP may result in sodium retention.
|
| dailymed-instance:indicatio... |
3% and 5% Sodium
Chloride Injection, USP is indicated as a source of water and electrolytes.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Sodium Chloride
|